Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

690 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.
Selinski S, Blaszkewicz M, Ickstadt K, Gerullis H, Otto T, Roth E, Volkert F, Ovsiannikov D, Moormann O, Banfi G, Nyirady P, Vermeulen SH, Garcia-Closas M, Figueroa JD, Johnson A, Karagas MR, Kogevinas M, Malats N, Schwenn M, Silverman DT, Koutros S, Rothman N, Kiemeney LA, Hengstler JG, Golka K. Selinski S, et al. Among authors: otto t. Carcinogenesis. 2017 Dec 7;38(12):1167-1179. doi: 10.1093/carcin/bgx102. Carcinogenesis. 2017. PMID: 29028944 Free PMC article.
N-acetyltransferase 1*10 genotype in bladder cancer patients.
Höhne S, Gerullis H, Blaszkewicz M, Selinski S, Hengstler JG, Otto T, Golka K. Höhne S, et al. Among authors: otto t. J Toxicol Environ Health A. 2017;80(7-8):417-422. doi: 10.1080/10937404.2017.1304727. Epub 2017 Jul 11. J Toxicol Environ Health A. 2017. PMID: 28696911
Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk.
Lehmann ML, Selinski S, Blaszkewicz M, Orlich M, Ovsiannikov D, Moormann O, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G, Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Seidel T, Roth G, Dietrich H, Ebbinghaus R, Prager HM, Bolt HM, Falkenstein M, Zimmermann A, Klein T, Reckwitz T, Roemer HC, Löhlein D, Weistenhöfer W, Schöps W, Beg AE, Aslam M, Bánfi G, Romics I, Ickstadt K, Schwender H, Winterpacht A, Hengstler JG, Golka K. Lehmann ML, et al. Among authors: otto t. Arch Toxicol. 2010 Dec;84(12):967-78. doi: 10.1007/s00204-010-0617-6. Epub 2010 Nov 10. Arch Toxicol. 2010. PMID: 21063684
Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene.
Selinski S, Lehmann ML, Blaszkewicz M, Ovsiannikov D, Moormann O, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G, Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Seidel T, Roth G, Volkert F, Ebbinghaus R, Prager HM, Lukas C, Bolt HM, Falkenstein M, Zimmermann A, Klein T, Reckwitz T, Roemer HC, Hartel M, Weistenhöfer W, Schöps W, Rizvi SA, Aslam M, Bánfi G, Romics I, Ickstadt K, Hengstler JG, Golka K. Selinski S, et al. Among authors: otto t. Arch Toxicol. 2012 Feb;86(2):195-203. doi: 10.1007/s00204-011-0747-5. Epub 2011 Sep 3. Arch Toxicol. 2012. PMID: 21892705
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
Selinski S, Lehmann ML, Blaszkewicz M, Ovsiannikov D, Moormann O, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G, Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Seidel T, Roth G, Volkert F, Ebbinghaus R, Prager HM, Bolt HM, Falkenstein M, Zimmermann A, Klein T, Reckwitz T, Roemer HC, Hartel M, Weistenhöfer W, Schöps W, Rizvi SA, Aslam M, Bánfi G, Romics I, Ickstadt K, Hengstler JG, Golka K. Selinski S, et al. Among authors: otto t. Arch Toxicol. 2012 Sep;86(9):1369-78. doi: 10.1007/s00204-012-0854-y. Epub 2012 Apr 25. Arch Toxicol. 2012. PMID: 22532026
Occupational risk factors for relapse-free survival in bladder cancer patients.
Selinski S, Bürger H, Blaszkewicz M, Otto T, Volkert F, Moormann O, Niedner H, Hengstler JG, Golka K. Selinski S, et al. Among authors: otto t. J Toxicol Environ Health A. 2016;79(22-23):1136-1143. doi: 10.1080/15287394.2016.1219606. J Toxicol Environ Health A. 2016. PMID: 27924711
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype.
Selinski S, Blaszkewicz M, Lehmann ML, Ovsiannikov D, Moormann O, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G, Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Seidel T, Roth G, Dietrich H, Ebbinghaus R, Prager HM, Bolt HM, Falkenstein M, Zimmermann A, Klein T, Reckwitz T, Roemer HC, Löhlein D, Weistenhöfer W, Schöps W, Hassan Rizvi SA, Aslam M, Bánfi G, Romics I, Steffens M, Ekici AB, Winterpacht A, Ickstadt K, Schwender H, Hengstler JG, Golka K. Selinski S, et al. Among authors: otto t. Pharmacogenet Genomics. 2011 Oct;21(10):673-8. doi: 10.1097/FPC.0b013e3283493a23. Pharmacogenet Genomics. 2011. PMID: 21750470
Targeted agents in second-line bladder cancer therapy.
Gerullis H, Otto T, Ecke TH. Gerullis H, et al. Among authors: otto t. Anticancer Drugs. 2012 Nov;23(10):1003-15. doi: 10.1097/CAD.0b013e3283582a33. Anticancer Drugs. 2012. PMID: 22914698 Review.
690 results